1.Bruce, M, Fraser, H.Amyloid plaques in the brains of mice infected with Scrapie: morphological variation and staining properties. Neuropathology and Applied Neurobiology 1975; 1: 189–202.
2.Wisniewski, HM, Bruce, M, Fraser, H.Infectious etiology of neuritic (senile) plaques in mice. Science 1975: 190: 1108–1110.
3.Dickinson, AG, Bruce, ME, Scott, JR. In: Katzman, R (ed), Banbury Report 15, Biological aspects of Alzheimer’s Disease. New York, Cold Spring Harbor Laboratory Press 1983; 387–398.
4.Wietgrefe, S, Zupancic, M, Hasse, A, Chesebro, B, Race, R, Frey, IIW, Rustan, T, Friedman, RL.Cloning of a gene whose expression is increased in scrapie and in senile plaques in human brain. Science 1985; 230: 1177–1179.
5.Bruce, M.Scrapie and Alzheimer’s Disease. Physiological Medicine 1984; 14: 497–500.
6.Somerville, RA.Ultrastructural links between scrapie and Alzheimer’s Disease. Lancet March 1985; 504–506.
7.Glenner, CW, Wong, CW.Alzheimer’s Disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical Biophysical Res Comm 1984; 120: 885–890.
8.Masters, CL, Simms, G, Weinman, NA, Multhaup, G, McDonald, BL, Beyreuther, K.Amyloid plaque core protein in Alzheimer Disease and Down’s Syndrome. Proc Natl Acad Sci 1985; 82: 4245–4249.
9.Prusiner, SB.Prions: Novel infectious pathogens in advances in virus research. Academic Press 1984; 29: 1–56.
10.Chesebro, B, Race, R, Wehrly, K, Nishio, J, Bloom, M, Lechner, D, Bergstrom, S, Robbins, K, Mayer, L, Keith, JM, Garon, C, Hasse, A.Identification of scrapie prion protein specific mRNA in scrapie infected and uninfected brain. Nature 1985, 315: 331–333.
11.Crapper, DR, Quittkat, S, De Boni, U.Altered chromatin conformation in Alzheimer’s Disease. Brain 1979; 102: 483–495.
12.Lewis, PN, Lukiw, WJ, De Boni, U, Crapper McLachlan, DR.Changes in chromatin structure associated with Alzheimer’s Disease. J Neurochem November 1981; 37: 1193–1202.
13.Crapper McLachlan, DR, Lewis, PN, Lukiw, WJ, Sima, A, Bergeron, C, de Boni, U.Chromatin structure in dementia. Ann Neurol 1984; 15: 329–334.
14.Chatigny, MA, Prusiner, SB.Biohazards and risk assessment of laboratory studies on the agents causing the spongiform encephalopathies in slow transmissible diseases of the nervous system. Academic Press 1979; 2: 491–514.
15.Burton, K.Determination of DNA concentration with diphenylamine. Methods Enzymol 1968; 12B: 163–166.
16.Cesarone, CF, Bolognesi, C, Santi, L.Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem 1979; 100: 188–197.
17.Biorad Technical Bulletin Biorad Protein Assay No. 1069; February 1979.
18.Heins, JN, Suriano, RJ, Taniuchi, H, Anfinsen, CB.Characterization of a nuclease produced by staphylococcus aureus. J Biol Chem 1967; 242 No. 5.
19.Thoma, F, Roller, T, Klug, A.Involvement of histone HI in the organization of the nucleosome and of the salt dependent superstructure of chromatin. J Cell Biol 1979; 83: 403–427.
20.Manning, EJ, Lax, AJ, Kimberlin, RH.Polyadenylated RNA and scrapie in mice. Veterinary Microbiology 1982; 7: 267–271.
21.Bountiff, L, Hunter, GD.Observations on a change in the low molecular weight cytoplasmic RNA in the brains of scrapie affected mice transactions. Biochemical Society 1982; 10:454–458.
22.German, TL, McMillan, BC, Castle, BE, Dees, C, Wade, WF, Marsh, RF.Comparison of RNA from healthy and scrapie affected hamster brain. J Gen Virology 1985; 66: 839–844.
23.Lerner, MR, Steitz, JA.Snurps and Scyrps. Cell 1981;25:298–300.
24.Lukiw, WJ, Lewis, PN, McLachlan, DR.Analysis of chromatin from senile dementia affected brains. 12th International Congress of Biochemistry, Perth, Western Australia, August 1982; Poster Abstract 003–98.
25.Lukiw, WJ, Kruck, TPA and Crapper McLachlan, DR.Alterations in human linker histone — DNA binding in the presence of aluminum salts in vitro and in Alzheimer’s Disease. Submitted to Neuro Toxicology 1986.
26.Sadjel-Sulkowska, EM, Coughlin, JF, Staton, DM, Marotta, CA.In vitro protein synthesis by messenger RNA from the Alzheimer’s Disease brain from biological aspects of Alzheimer’s Disease. C.S.H.S.Q.B. Banbury Report No. 15, Katzman, R Editor, New York, 1982.
27.Guillemette, JG, Wong, L, Crapper McLachlan, DR, Lewis, PN.Characterization of messenger RNA from the cerebral cortex of control and Alzheimer affected brain. J Neurochem 1986; 47: 987–997.